News
A Food and Drug Administration (FDA) expert panel has reignited a debate over whether hormone therapy should be used to treat ...
2d
Everyday Health on MSNNew FDA Panel Recommends Removing Warnings From Estrogen Therapies for MenopauseThe panelists said that vaginal creams and other localized therapies for menopause are safe and vastly underused by women who ...
The debate over whether to use hormone therapy to treat menopausal women continues, as a Food and Drug Administration (FDA) expert panel weighs in. The panel, consisting […] ...
Experts worry the warning on vaginal estrogen menopause treatments is doing more harm than good and is not supported by science.
Hone Health reports that the controversial 2002 WHI study misled menopause care, linking HRT to breast cancer and causing ...
Bypassing its standard pathways for scientific discussions, FDA has recently held a slew of so-called "expert panels" that ...
JUUL GETS ITS CROWN — The FDA authorized Juul’s applications on Thursday to sell e-cigarettes in the U.S., determining ...
4d
MedPage Today on MSNFDA Names Former Pharma Executive to Oversee U.S. Drug ProgramFDA Commissioner Marty Makary, MD, MPH, announced that George Tidmarsh, MD, PhD, a cancer and pediatric specialist, will ...
There are a few important steps, but getting an online testosterone prescription is actually much easier than it might appear ...
2d
News-Medical.Net on MSNCan one drug do it all? Reviewing the expanding clinical universe of GLP-1 agonistsLandmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...
The PMCPA ruled that “a systemic failure in compliance oversight” at Theramex has brou | The PMCPA ruled that “a systemic ...
Pedro C. Barata, MD, MSc, discusses the advantages and disadvantages of darolutamide in metastatic hormone-sensitive prostate cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results